FDA Inspection 819131 — Zhejiang Excel Pharmaceutical Company, Ltd.
The FDA completed an inspection of Zhejiang Excel Pharmaceutical Company, Ltd. on Jan 31, 2013 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 31, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)